Fresenius Group Overview

Bonds & Convertible Bonds

  • European Medium Term Note Program

    The information and documents contained on the following pages of this website are for information purposes only. These materials do neither constitute an offer nor an invitation to subscribe to or to purchase securities, nor any investment advice or service, and are not meant to serve as a basis for any kind of obligation, contractual or otherwise. Securities may not be offered or sold in the United States of America (“US”) absent registration under the US Securities Act of 1933, as amended, or an exemption from registration. The securities described on the following pages are not offered for sale in the US or to "US persons" (as defined in Regulation S under the US Securities Act of 1933, as amended).

     

    THE FOLLOWING INFORMATION AND DOCUMENTS ARE NOT DIRECTED AT AND ARE NOT INTENDED FOR USE BY (I) PERSONS WHO ARE RESIDENTS OF OR LOCATED IN THE US, CANADA, JAPAN OR AUSTRALIA OR WHO ARE US PERSONS (AS DEFINED IN REGULATION S UNDER THE US SECURITIES ACT OF 1933, AS AMENDED), OR (II) PERSONS IN ANY OTHER JURISDICTION WHERE THE COMMUNICATION OR RECEIPT OF SUCH INFORMATION IS RESTRICTED IN SUCH A WAY THAT PROVIDES THAT SUCH PERSONS SHALL NOT RECEIVE IT. SUCH PERSONS, OR PERSONS ACTING FOR THE BENEFIT OF ANY SUCH PERSONS, ARE NOT PERMITTED TO VISIT THE FOLLOWING PAGES OF THE WEBSITE.

     

    To visit the following parts of this website you must confirm that
    (i) you are not a resident of the United States of America, Canada, Japan or Australia or a "US person" (as defined in Regulation S under the US Securities Act of 1933, as amended),
    (ii) you are not a person to whom the communication of the information contained on the website is restricted,
    (iii) you will not distribute any of the information and documents contained thereon to any such person, and
    (iv) you are not acting for the benefit of any such person.

     

    By clicking on the "Accept" button below, you will be deemed to have made this confirmation

     


     

Bonds
Issuer Volume in million Coupon Maturity
Fresenius SE & Co. KGaA €500 2.875% 2020
Fresenius SE & Co. KGaA €450 3.00% 2021
Fresenius SE & Co. KGaA €450 4.00% 2024
Fresenius SE & Co. KGaA €500 1.875% 2025
Fresenius SE & Co. KGaA €500 2.875% 2029
Fresenius Finance Ireland plc. €700 0.875% 2022
Fresenius Finance Ireland plc. €700 1.50% 2024
Fresenius Finance Ireland plc. €700 2.125% 2027
Fresenius Finance Ireland plc. €500 3.00% 2032
Fresenius US Finance II, Inc. $300 4.250% 2021
Fresenius US Finance II, Inc. $300 4.50% 2023
FMC Finance VII S.A. €300 5.25% 2021
Fresenius Medical Care US Finance, Inc. $650 5.75% 2021
Fresenius Medical Care US Finance II, Inc. $500 4.125 % 2020
Fresenius Medical Care US Finance II, Inc. $700 5.875 % 2022
Fresenius Medical Care US Finance II, Inc. $400 4.75 % 2024
Fresenius Medical Care US Finance III, Inc $500 3.75 % 2029
Fresenius Medical Care AG & Co. KGaA €500 1.50% 2025

 

  • Equity-neutral convertible bonds 2014 – 2019

     

    Issuer

    Fresenius SE & Co. KGaA

     

    Currency
    Issue amount

    500,000,000

    Value date

    March 24, 2014

    Maturity

    September 24, 2019

    Coupon

    0%

    Issue price

    100%

    Rating

    BBB / Baa3 / BBB-

    Initial conversion premium

    35%

    Current conversion price

    €48.6457

    Current conversion ratio

    2,055.68015
    Conversion period From March 24, 2017 until August 12, 2019
    Conversion Cash settled1
    Stock exchange

    Frankfurt / Open Market (Freiverkehr)

    Denomination

    100,000

    Clearing agency

    Clearstream Frankfurt

    ISIN Code

    DE000A1YC3T6

     

     

    Any increase of Fresenius' share price above the conversion price would be offset by a corresponding value increase of the call options; dilution of Fresenius' share capital through issuance of new shares in connection with this transaction is ruled out.

    1 Subject to certain exceptions which would result in delivery of Fresenius shares by a third party.

     

     

     

     


     

  • Equity-neutral convertible bonds 2017 – 2024

    Issuer

    Fresenius SE & Co. KGaA

    Currency
    Issue amount

    500,000,000

    Value date

    January 31, 2017

    Maturity

    January 31, 2024

    Coupon

    0 %

    Issue price

    101.00%

    Rating

    BBB / Baa3 / BBB-

    Actual conversion price

       €106.4928

    Actual conversion ratio  939.03062
    Conversion period From August 31, 2023 until November 7, 2023
    Conversion Cash settled
    Stock exchange

    Frankfurt / Open Market (Freiverkehr)

    Denomination

    €100,000

    Clearing agency

    Clearstream Frankfurt

    ISIN

    DE000A2DAHU1

     

    Any increase of Fresenius' share price above the conversion price would be offset by a corresponding value increase of the call options; dilution of Fresenius' share capital through issuance of new shares in connection with this transaction is ruled out.